The study evaluates the effect of the 2020 Centers for Disease Control and Prevention and U.S. Preventive Services Task Force recommendations on hepatitis C virus (HCV) screening among pregnant persons nationally and by health insurance type. The study included 5,048,428 pregnant persons aged 15-44 years with either Medicaid or commercial health insurance who had obstetric panel testing performed by Quest Diagnostics, January 2011-June 2021. Antibody screening for HCV infection increased before and accelerated after the updated recommendations in early 2020. Disparities in HCV testing by health insurance status were substantial over the entire study period. Despite substantial progress in the proportion of pregnant persons screened for HCV infection, current testing rates fall short of universal recommendations.

中文翻译：

---

普遍筛查建议后的妊娠期丙型肝炎病毒检测。

该研究评估了 2020 年疾病控制与预防中心和美国预防服务工作组对全国孕妇丙型肝炎病毒 (HCV) 筛查和健康保险类型的建议的影响。该研究包括 5,048,428 名年龄在 15-44 岁之间的孕妇，他们在 2011 年 1 月至 2021 年 6 月期间接受了由 Quest Diagnostics 进行的产科专家组检测，他们有 Medicaid 或商业健康保险。在 2020 年初更新的建议之前和之后加速了 HCV 感染的抗体筛查. 在整个研究期间，不同健康保险状况的 HCV 检测差异很大。尽管筛查 HCV 感染的孕妇比例取得了​​实质性进展，但目前的检测率仍低于普遍建议。